$117.570
+5.926 (+5.04%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MNPR por análisis de gráficos similares
Alphio's MNPR stock price prediction model matches the current Monopar Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $118.24 (+0.57%). The 1-week path is $118.53 (+0.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Monopar Therapeutics Inc?
Monopar Therapeutics Inc is a good buy right now due to its recent stock price of $111.89, which is significantly lower than the analyst price target of $133 from BTIG. The company has shown a remarkable year-to-date change of +69.50% and a one-year change of +229.77%, indicating strong momentum. However, the main risk is the negative net income reported for Q2 2026, which was -5,313,300 USD, suggesting ongoing financial challenges that investors should monitor closely.
MNPR cerró en $117.57 el Tuesday, tras subir +5.04%
Monopar Therapeutics Inc (MNPR) last closed at $117.57, gaining +5.04%. These facts feed the 1-day and 1-week MNPR price prediction above.
Factores de la previsión
Los factores de la previsión de Monopar Therapeutics Inc (MNPR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MNPR, ordenadas por similitud.
Análisis de estacionalidad de MNPR
Historically the probability of a positive September return for MNPR is 100.00%. July offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MNPR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $45.38 | $49.94 | $52.77 | -57.52% |
| Oct 2026 | $49.44 | $49.76 | $51.59 | -57.67% |
| Nov 2026 | $37.98 | $45.86 | $55.22 | -61.00% |
| Dec 2026 | $33.98 | $42.59 | $43.27 | -63.78% |
En 2026, se proyecta que Monopar Therapeutics Inc (MNPR) oscile entre $33.98 y $55.22.
Previsión mensual de Monopar Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Monopar Therapeutics Inc promedie $49.94, con un mínimo de $45.38 y un máximo de $52.77.
En Oct de 2026, se proyecta que Monopar Therapeutics Inc promedie $49.76, con un mínimo de $49.44 y un máximo de $51.59.
En Nov de 2026, se proyecta que Monopar Therapeutics Inc promedie $45.86, con un mínimo de $37.98 y un máximo de $55.22.
En Dec de 2026, se proyecta que Monopar Therapeutics Inc promedie $42.59, con un mínimo de $33.98 y un máximo de $43.27.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.